Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study
- PMID: 23197573
- DOI: 10.1530/EJE-12-0702
Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study
Abstract
Objective: Long-term health sequelae of childhood-onset acute lymphoblastic leukemia (ALL) remain largely unknown. Low bone mineral content (BMC) and bone mineral density (BMD) are recognized complications, but it is unknown whether these persist until adulthood. We evaluated skeletal characteristics and their association with ALL therapy in long-term male ALL survivors.
Design: This cross-sectional cohort study included 49 long-term male ALL survivors and 55 age-matched healthy males.
Methods: BMD and compression fractures were assessed by dual-energy X-ray absorptiometry; blood biochemistry was obtained for parameters of calcium homeostasis.
Results: The ALL survivors (median age 29 years, range 25-38 years), assessed 10-38 years after ALL diagnosis, had lower lumbar spine (P<0.001), femoral neck (P<0.001), and whole-body (P=0.017) BMD than expected based on normative values. When compared with the controls (median age 30 years, range 24-36 years), the ALL survivors had lower lumbar spine BMC (P=0.014), lower whole-body BMC (P<0.001), and lower whole-body BMD (P<0.001), but the differences were partly explained by differences in height. Altogether, 20% of the ALL survivors had spinal compression fractures, but these were equally prevalent in the controls. Males diagnosed with ALL before age 5 years had significantly lower BMD values. Other recognized risk factors included untreated hypogonadism, vitamin D deficiency, hypophosphatemia, low IGF-binding protein-3, and low physical activity.
Conclusions: At young adulthood, long-term male ALL survivors have significantly reduced BMC and BMD and a high prevalence of spinal compression fractures. Careful follow-up and active treatment of the recognized risk factors are warranted.
Similar articles
-
Skeletal morbidity in childhood acute lymphoblastic leukemia.J Clin Oncol. 2004 Apr 1;22(7):1215-21. doi: 10.1200/JCO.2004.04.199. J Clin Oncol. 2004. PMID: 15051768 Clinical Trial.
-
Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.Cancer. 2020 Jan 1;126(1):202-210. doi: 10.1002/cncr.32512. Epub 2019 Sep 19. Cancer. 2020. PMID: 31536650
-
No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26271. Epub 2016 Sep 26. Pediatr Blood Cancer. 2017. PMID: 27671543
-
Aqua-Plyometric Exercises: Potential Implications for Bone Mineral Density, Functional Capacity, and Quality of Life in Survivors of Childhood Acute Lymphoblastic Leukemia.Semin Oncol Nurs. 2021 Dec;37(6):151225. doi: 10.1016/j.soncn.2021.151225. Epub 2021 Nov 6. Semin Oncol Nurs. 2021. PMID: 34753640 Review.
-
Bone and bone turnover.Endocr Dev. 2009;15:77-100. doi: 10.1159/000207611. Epub 2009 Mar 3. Endocr Dev. 2009. PMID: 19293605 Review.
Cited by
-
A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.Front Endocrinol (Lausanne). 2024 Jan 25;14:1266986. doi: 10.3389/fendo.2023.1266986. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38374961 Free PMC article. Review.
-
Clinical applicability of short form of Bruininks-Oseretsky Test of Motor Proficiency Second Edition in patients after treatment of acute lymphoblastic leukemia.Front Pediatr. 2023 Apr 3;11:1071572. doi: 10.3389/fped.2023.1071572. eCollection 2023. Front Pediatr. 2023. PMID: 37077337 Free PMC article.
-
Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives.Cancers (Basel). 2022 Sep 6;14(18):4349. doi: 10.3390/cancers14184349. Cancers (Basel). 2022. PMID: 36139510 Free PMC article. Review.
-
Evaluating the Effect of Induction Chemotherapy on Bone Metabolizing Nutrients in Patients of Acute Lymphoblastic Leukemia.Cureus. 2022 May 27;14(5):e25403. doi: 10.7759/cureus.25403. eCollection 2022 May. Cureus. 2022. PMID: 35774667 Free PMC article.
-
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.Pharmacogenomics J. 2022 Feb;22(1):19-24. doi: 10.1038/s41397-021-00252-6. Epub 2021 Aug 26. Pharmacogenomics J. 2022. PMID: 34446917
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical